Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies. | Curr Oncol Rep | 2022 | 35362827 | PubTator, text mining | PubMed |
| Cell cycle regulation: p53-p21-RB signaling. | Cell Death Differ | 2022 | 35361964 | PubTator, text mining | PubMed |
| FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironment. | PLoS One | 2022 | 35358193 | PubTator, text mining | PubMed |
| Hydrostatic pressure induces profibrotic properties in hepatic stellate cells via the RhoA/ROCK signaling pathway. | FEBS Open Bio | 2022 | 35357779 | PubTator, text mining | PubMed |
| Investigation of hub genes involved in Turner syndrome using biological informatics methods. | Medicine (Baltimore) | 2022 | 35356930 | PubTator, text mining | PubMed |
| DNA methylation biomarkers in asthma and rhinitis: Are we there yet? | Clin Transl Allergy | 2022 | 35344303 | PubTator, text mining | PubMed |
| Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders. | Mol Omics | 2022 | 35343995 | PubTator, text mining | PubMed |
| Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease. | Curr Res Transl Med | 2022 | 35339032 | PubTator, text mining | PubMed |
| Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis. | Molecules | 2022 | 35335125 | PubTator, text mining | PubMed |
| Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. | J Hematol Oncol | 2022 | 35331296 | PubTator, text mining | PubMed |
| Hepatocyte Proteome Alterations Induced by Individual and Combinations of Common Free Fatty Acids. | Int J Mol Sci | 2022 | 35328776 | PubTator, text mining | PubMed |
| Is Autophagy Always a Barrier to Cisplatin Therapy? | Biomolecules | 2022 | 35327655 | PubTator, text mining | PubMed |
| Nuclear receptor activation shapes spatial genome organization essential for gene expression control: lessons learned from the vitamin D receptor. | Nucleic Acids Res | 2022 | 35325193 | PubTator, text mining | PubMed |
| Fucoidan (Undaria pinnatifida)/Polydopamine Composite-Modified Surface Promotes Osteogenic Potential of Periodontal Ligament Stem Cells. | Mar Drugs | 2022 | 35323480 | PubTator, text mining | PubMed |
| Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2. | Bioengineered | 2022 | 35322742 | PubTator, text mining | PubMed |
| Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway. | Aging Cell | 2022 | 35315217 | PubTator, text mining | PubMed |
| Candidate master microRNA regulator of arsenic-induced pancreatic beta cell impairment revealed by multi-omics analysis. | Arch Toxicol | 2022 | 35314868 | PubTator, text mining | PubMed |
| The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. | PLoS Pathog | 2022 | 35312737 | PubTator, text mining | PubMed |
| Therapeutic targeting of mitophagy in Parkinson's disease. | Biochem Soc Trans | 2022 | 35311891 | PubTator, text mining | PubMed |
| Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice. | Biochem Biophys Res Commun | 2022 | 35303680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=48